Clinical trial
Patient Journey With Advanced Lung Cancer Positive for ALK Fusion in Brazil
NCT04947683 is registered in ClinicalTrials.gov with Latin American Cooperative Oncology Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Patient Journey With Advanced Lung Cancer Positive for ALK Fusion in Brazil
- Lead sponsor
- Latin American Cooperative Oncology Group
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 6, 2020
- Completion date
- March 3, 2023
- Enrollment
- 101 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.